(PRWEB) March 23, 2016
Docket Alarm, a leader in technology enabled legal analysis, has released a new report visually depicting how the Patent Trial and Appeal Board is affecting pharmaceutical litigation. Compiled from data gathered on Docket Alarm’s PTAB and Orange Book analytics platform, “Big Pharma and the Legal Industry: Docket Alarm’s Guide to Orange Book Patent Analytics” gives lawyers insight into how this new tribunal is changing a billion dollar industry.
The PTAB, founded less than four years ago, is already having a noticeable impact on Hatch-Waxman litigation. The new infographic depicts key attributes of big pharma patent litigation, including:
- New Drug Applications: How many new NDA and ANDA filings there are at the FDA.
- The PTAB’s Effect on Orange Book Litigation: How often drug patents are being invalidated at the PTAB.
- How Drug Patents Compare: How Orange Book patents compare to non-drug patents at the PTAB.
- The Top Players, Judges, and Law Firms: View stats on the top PTAB players in the Orange Book sector, including the top petitioners challenging Orange Book patents, top patent owners, law firms, and judges.
The new report is available at:
Those interested in learning more can contact Docket Alarm at info(at)docketalarm(dot)com.
About Docket Alarm
Docket Alarm is the only research platform that offers patent practitioners a complete PTAB research and analytics platform featuring Orange Book litigation. Add intelligence to your patent practice today by signing up at http://www.docketalarm.com/welcome/Orange-Book-Research-Tools.